XML 40 R28.htm IDEA: XBRL DOCUMENT v3.25.1
Revenue (Tables)
 6 Months Ended
Mar. 31, 2025
Revenue from Contract with Customer [Abstract]  
Contract with Customer, Contract Asset, Contract Liability, and Receivable
The following table summarizes our contract balances:
(in thousands) March 31,
2025		September 30,
2024
Contract assets(1)
$1,475 $2,031 
Contract liabilities(2)
1,988 2,131 
(1) Consists of unbilled amounts primarily related to Biopharma contracts which consists of research and development agreements with third parties.
(2) Consists of receipt of advance payment before our performance obligations related to Biopharma contracts are met.
Summary of Revenue by Geographic Region
The table below sets forth revenues by geographic region, based on ship-to destinations. Americas consists of the United States, Canada, Mexico and South America; EMEA consists of Europe, the Middle East, and Africa; and APAC consists of Japan, China, South Korea, India, Singapore, Malaysia and Australia.

Three Months Ended
March 31,		Six Months Ended
March 31,
(in thousands)2025202420252024
Americas$55,189 $45,873 $108,899 $89,832 
EMEA30,64222,26358,94543,483
APAC6,9627,16613,66213,485
Total$92,793 $75,302 $181,506 $146,800 
Summary of Revenue by Product
The table below sets forth revenues by products.
Three Months Ended
March 31,		Six Months Ended
March 31,
(in thousands)2025202420252024
Synthetic genes$28,222 $22,356 $54,708 $42,083 
Oligo pools4,7113,9409,8048,129
DNA libraries3,0173,5315,8116,470
Antibody discovery5,6974,70111,3959,927
NGS tools51,14640,77499,78880,191
Total$92,793 $75,302 $181,506 $146,800 
Summary of Revenue by Industry
The table below sets forth revenues by industry.

Three Months Ended
March 31,		Six Months Ended
March 31,
(in thousands)2025202420252024
Industrial chemicals/materials$22,795 $20,264 $43,998 $36,542 
Academic research16,52713,72234,07327,495
Healthcare52,76640,934102,13581,815
Food/agricultural7053821,300948
Total$92,793 $75,302 $181,506 $146,800